Microneedle Array‐Based Platforms for Future Theranostic Applications - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue ChemBioChem Année : 2019

Microneedle Array‐Based Platforms for Future Theranostic Applications

Résumé

Theranostics involves finding the biomarkers of a disease, fighting them through site specific drug delivery and following them for prognosis of the disease. Microneedle array technology has been used for drug delivery and extended for continuous monitoring of analytes present in the skin compartment. We envisage the use of microneedle arrays for future theranostic applications. The potential of combining microneedle array-based drug delivery and diagnostics as part of closed-loop control system for the management of diseases and delivery of precision drugs in individual patients is reported in this paper.

Dates et versions

hal-03025319 , version 1 (26-11-2020)

Identifiants

Citer

Olivia Howells, Natasha Rajendran, Sarah Mcintyre, Sara Amini‐asl, Pauline Henri, et al.. Microneedle Array‐Based Platforms for Future Theranostic Applications. ChemBioChem, 2019, 20 (17), pp.2198-2202. ⟨10.1002/cbic.201900112⟩. ⟨hal-03025319⟩
21 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More